Treatment with biologics during pregnancy in patients with rheumatic diseases

por Förger, Frauke
Publicado 2017

Is IgG galactosylation the relevant factor for pregnancy-induced remission of rheumatoid arthritis?

por Förger, Frauke, Østensen, Monika
Publicado 2010

Aktuelles zur antirheumatischen Therapie bei Kinderwunsch, Schwangerschaft und Stillzeit

por Häfeli, Celine, Förger, Frauke
Publicado 2021

Rituximab and Canakinumab Use During Lactation: No Detectable Serum Levels in Breastfed Infants

por Bosshard, Nicole, Zbinden, Astrid, Eriksson, Klara Kristin, Förger, Frauke
Publicado 2021

Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study

por Möller, Burkhard, Scherer, Almut, Förger, Frauke, Villiger, Peter M, Finckh, Axel
Publicado 2014

Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients

por van den Brandt, Stephanie, Zbinden, Astrid, Baeten, Dominique, Villiger, Peter M., Østensen, Monika, Förger, Frauke
Publicado 2017

Reduced pro-inflammatory profile of γδT cells in pregnant patients with rheumatoid arthritis

por Tham, Manuela, Schlör, Gabriele R., Yerly, Daniel, Mueller, Christina, Surbek, Daniel, Villiger, Peter M., Förger, Frauke
Publicado 2016

European Network of Pregnancy Registers in Rheumatology (EuNeP)—an overview of procedures and data collection

por Meissner, Yvette, Strangfeld, Anja, Costedoat-Chalumeau, Nathalie, Förger, Frauke, Goll, Doreen, Molto, Anna, Özdemir, Rebecca, Wallenius, Marianne, Fischer-Betz, Rebecca
Publicado 2019

Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol

por Clowse, Megan, Fischer-Betz, Rebecca, Nelson-Piercy, Catherine, Scheuerle, Angela E., Stephan, Brigitte, Dubinsky, Marla, Kumke, Thomas, Kasliwal, Rachna, Lauwerys, Bernard, Förger, Frauke
Publicado 2022

Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database

por Clowse, Megan E. B., Scheuerle, Angela E., Chambers, Christina, Afzali, Anita, Kimball, Alexa B., Cush, John J., Cooney, Maureen, Shaughnessy, Laura, Vanderkelen, Mark, Förger, Frauke
Publicado 2018

Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study

por Clowse, Megan EB, Förger, Frauke, Hwang, Caroline, Thorp, John, Dolhain, Radboud JEM, van Tubergen, Astrid, Shaughnessy, Laura, Simpson, Jeff, Teil, Marie, Toublanc, Nathalie, Wang, Maggie, Hale, Thomas W
Publicado 2017

Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study

por Mariette, Xavier, Förger, Frauke, Abraham, Bincy, Flynn, Ann D, Moltó, Anna, Flipo, René-Marc, van Tubergen, Astrid, Shaughnessy, Laura, Simpson, Jeff, Teil, Marie, Helmer, Eric, Wang, Maggie, Chakravarty, Eliza F
Publicado 2018

EULAR recommendations for a core data set for pregnancy registries in rheumatology

por Meissner, Yvette, Fischer-Betz, Rebecca, Andreoli, Laura, Costedoat-Chalumeau, Nathalie, De Cock, Diederik, Dolhain, Radboud J E M, Forger, Frauke, Goll, Doreen, Molto, Anna, Nelson-Piercy, Catherine, Özdemir, Rebecca, Raio, Luigi, Rodríguez-García, Sebastian Cruz, Sciascia, Savino, Wallenius, Marianne, Zbinden, Astrid, Zink, Angela, Strangfeld, Anja
Publicado 2021